SCHEDULE 13D

Beneficial Ownership Report

Passage BIO, Inc. Filed 2026-07-02 Acc 0000902664-26-003000

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-07-02 SCHEDULE 13D Beneficial Ownership Report
2026-06-29 4 10% owner bought 50,055 shares at $4.12 ($206,101)
2026-06-25 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)